A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria-Reference-Cited by-同舟云学术

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

Published:2011-09 Issue:3 Volume:128 Page:567-573.e1
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Saini Sarbjit,Rosen Karin E.,Hsieh Hsin-Ju,Wong Dennis A.,Conner Edward,Kaplan Allen,Spector Sheldon,Maurer Marcus

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference29 articles.

1. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria;Zuberbier;Allergy,2009

2. Chronic idiopathic urticaria;Greaves;Curr Opin Allergy Clin Immunol,2003

3. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity;Staubach;Br J Dermatol,2006

4. The impact of chronic urticaria on the quality of life;O’Donnell;Br J Dermatol,1997

5. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity;Sabroe;J Allergy Clin Immunol,2002

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials;Clinical Drug Investigation;2024-09-06

2. Successful serial plasmapheresis for solar urticaria, a case report and literature review;Journal of Dermatological Treatment;2024-06-16

3. Clinical features and potential markers of disease in idiopathic non-histaminergic angioedema, a real-life study;Immunologic Research;2024-06-03

4. The future of targeted therapy in chronic spontaneous urticaria;Annals of Allergy, Asthma & Immunology;2024-06

5. Impact of Omalizumab Treatment on Quality of Life and Activity of Chronic Spontaneous Urticaria;Eurasian Journal of Critical Care;2024-05-02